-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on National Health Investors, Maintains $88 Price Target

Benzinga·03/17/2025 13:23:42
Listen to the news
Wedbush analyst Richard Anderson reiterates National Health Investors (NYSE:NHI) with a Outperform and maintains $88 price target.